Global FPI for MAC in Atopic Dermatitis Trial
Ziarco Initiates Phase 2a Clinical Trial of ZPL-389 in Atopic Dermatitis.
June 10, 2015
Ziarco Initiates Phase 2a Clinical Trial of ZPL-389 in Atopic Dermatitis.
Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.